“Overall, our confidence is relatively high in being able to...

“Overall, our confidence is relatively high in being able to continue to supply American families in whatever shape or form, regulatory-wise, beyond the 14th of November. We’re just working with the [FDA] in terms of how that might look for it to be seamless,” Lin said.

The US, which is still grappling with an infant formula shortage that began in February, is experiencing out-of-stock rates of 74 per cent, according to retail tracking data. Lin doesn’t expect the shortage to ease until September. “This is far from a short-term thing,” he said.